MedFluid are committed to develop microfluidic platforms for rapid detection tools of disease diagnosis and precision treatments to improve the health and well-being of patients. 

Currently our main products were automated microfluidic systems based on integrated pneumatic membrane-type microfluidic chips,  providing rapid detection of infectious diseases as well as in-vitro drug susceptibility test. In addition to developing microfluidic-based diagnostics technologies,  we also offer ODM services for the customized microfluidic chip and its control system across different biomedical applications.